Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
1R01CA070853-01
Application #
2114647
Study Section
Experimental Therapeutics Subcommittee 1 (ET)
Project Start
1996-05-01
Project End
1999-04-30
Budget Start
1996-05-01
Budget End
1997-04-30
Support Year
1
Fiscal Year
1996
Total Cost
Indirect Cost
Name
Roswell Park Cancer Institute Corp
Department
Type
DUNS #
City
Buffalo
State
NY
Country
United States
Zip Code
14263
Marasco Jr, Canio J; Pera, Paula J; Spiess, Arthur J et al. (2005) Improved synthesis of beta-D-6-methylpurine riboside and antitumor effects of the beta-D- and alpha-D-anomers. Molecules 10:1015-20
Dimitroff, C J; Klohs, W; Sharma, A et al. (1999) Anti-angiogenic activity of selected receptor tyrosine kinase inhibitors, PD166285 and PD173074: implications for combination treatment with photodynamic therapy. Invest New Drugs 17:121-35
Dimitroff, C J; Pera, P; Dall'Olio, F et al. (1999) Cell surface n-acetylneuraminic acid alpha2,3-galactoside-dependent intercellular adhesion of human colon cancer cells. Biochem Biophys Res Commun 256:631-6
Dimitroff, C J; Sharma, A; Bernacki, R J (1998) Cancer metastasis: a search for therapeutic inhibition. Cancer Invest 16:279-90
Sharma, A; Glaves, D; Porter, C W et al. (1997) Antitumor efficacy of N1,N11-diethylnorspermine on a human bladder tumor xenograft in nude athymic mice. Clin Cancer Res 3:1239-44
Sharma, A; Bernacki, R J (1997) Ovarian cancer patients with high CA-125 but no symptoms--should antiangiogenic treatments be considered? Oncol Res 9:53-4
Sharma, A; Mayhew, E; Bolcsak, L et al. (1997) Activity of paclitaxel liposome formulations against human ovarian tumor xenografts. Int J Cancer 71:103-7
Woynarowska, B; Dimitroff, C J; Sharma, M et al. (1996) Inhibition of human HT-29 colon carcinoma cell adhesion by a 4-fluoro-glucosamine analogue. Glycoconj J 13:663-74